Practice gains access to world-class treatments and enhances its cutting-edge research program
Cincinnati, Ohio (November 1, 2016) – OHC (Oncology Hematology Care), the premier provider of advanced treatments for cancer and blood disorders in the Greater Cincinnati area for more than 30 years, has joined The US Oncology Network, one of the nation’s largest associations of community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. By joining The Network, OHC enhances its ability to provide patients high-quality care as well as access to some of the most advanced cancer treatments available today, all delivered in convenient neighborhood locations close to the patient’s home. The practice also gains a wealth of resources, expertise, innovative technologies and business support services from The Network to help them succeed in transitioning to value-based healthcare.
“We are excited to join The US Oncology Network, as it will allow us to retain our independence and maintain our community relationships while strengthening the financial and operational backbone of our practice for years to come,” said Randolph Broun, M.D., OHC medical oncologist and practice president. “The comprehensive resources and guidance from The Network will enable us to continue to provide the high level of cancer care our patients and referring physicians have come to know and expect, while enabling us to compete in the marketplace with greater operational and cost efficiency.”
The US Oncology Network is supported by McKesson Specialty Health, an industry leader in solutions that empower the community patient care delivery system to advance the science, technology and quality of care. This includes strong and comprehensive practice management capabilities and value-based care expertise critical for practices navigating today’s challenging healthcare landscape. OHC is one of more than 30 practices and over 1,000 physicians supported by McKesson Specialty Health nationally who have been selected to participate in the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM), representing roughly 32 percent of all physicians selected to participate in the program. This is a testament to the commitment of both organizations to value-based, high-quality care.
“It is extremely important to cancer patients and their families that community-based oncology practices like ours remain strong and independent in this era of provider consolidations and rising healthcare costs,” said Dr. Broun. “In addition to providing high-quality, cost-effective care, we also offer patients convenient access to leading-edge treatments, including clinical trials, right in their own neighborhood where they have the support of family and friends. Our affiliation with The US Oncology Network will help us continue to provide these cost-effective patient-centric services that support optimal patient outcomes while providing superior quality and value to both patients and payers.”
As part of The US Oncology Network, OHC will have access to expertise and resources from The Network typically only available in large academic medical centers. The practice can utilize the industry-leading clinical pathways developed by The Network that provide evidence-based treatment options based on efficacy, toxicity and cost, reducing treatment variability while driving better outcomes and more predictable costs. Physicians will also be able to collaborate on difficult cases with their colleagues across America through eTumor Boards and The Oncology Portal, tapping into the collective knowledge and experience of more than 1,000 physicians. Additionally, the practice will have access to a state-of-the-art drug distribution center specifically developed to increase patient safety, as well as exciting new technologies and programs to support oncology practices as they transition to value-based care delivery models.
While OHC already has a well-established, nationally recognized award-winning clinical research program, by uniting with The Network, the practice will greatly increase the number and variety of novel clinical trials it can offer patients through US Oncology Research, a leader in bringing innovative therapies to patients in local communities across the nation. The organization manages approximately 300 active trials at any given time and has played a role in more than 60 FDA-approved cancer therapies, about one-third of all those approved by the FDA to date.
“It is a privilege to have the respected physicians of OHC join The US Oncology Network,” said Kirk Kaminsky, president of The US Oncology Network and Practice Management for McKesson Specialty Health. “The addition of OHC to The Network expands our presence into another new market with a highly reputable, long-standing provider of high-quality community-based cancer care. We look forward to the many contributions this skilled group of physicians will make as we collaborate to advance the science and quality of cancer care in the new value-based healthcare landscape.”
About OHC
For more than 30 years, OHC has remained the region’s premier provider of treatments for adult cancer and complex blood disorders, offering a wide range of services, state-of-the-art treatments and leading edge technologies. As the only nationally accredited oncology medical home in Cincinnati, Ohio, OHC provides a comprehensive team approach delivering high-quality, compassionate, and convenient care, tailored to meet a patient’s medical and personal needs.
With more than 50 expert oncology providers, OHC treats nearly every form of adult cancer and complex blood disorders with medical, radiation, gynecologic, palliative and hospice oncology specialists. OHC offers nationally recognized clinical trials to help achieve groundbreaking advancements in the treatment of cancer and leads the most experienced adult blood and marrow transplant center in the tri-state area. With neighborhood locations throughout the tri-state area, OHC is one of the largest independent oncology practices in the United States. For more information visit www.ohcare.com.
About The US Oncology Network
The US Oncology Network is one of the nation’s largest networks of integrated, community-based oncology practices dedicated to advancing high-quality, evidence-based cancer care. A physician-led organization, The US Oncology Network unites like-minded physicians and clinicians around a common vision of improving patient outcomes and quality of life. Leveraging healthcare information technology, shared best practices, evidence-based guidelines and quality measurements, physicians within The US Oncology Network are pioneering new ways to achieve this vision. This includes participation in initiatives that are leading the way toward value-based care such as the Center for Medicare & Medicaid Innovation (CMMI) Oncology Care Model (OCM). The US Oncology Network is committed to strengthening patient access to integrated care in local communities across the nation, including collaboration with a variety of payers, hospitals and academic institutions. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system. For more information, visit www.usoncology.com.